Amgen Financial Diagnostics

Amgen Inc -- USA Stock  

USD 169.38  0.62  0.36%

Amgen Inc diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 80.0% of the company shares are held by institutions such as insurance companies. Book value of Amgen Inc was presently as 43.41. The company recorded earning per share (EPS) of 10.98. Amgen Inc last dividend was issued on 2017-11-16. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. For more info on AMGEN please contact Robert Bradway at 805 447-1010 or go to www.amgen.com.

Amgen Inc Alerts

Amgen Inc generates negative expected return over the last 30 days
Amgen Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 80.0% of the company shares are held by institutions such as insurance companies
On November 16, 2017 Amgen paid $ 1.15 per share dividend to its current shareholders
Latest headline from www.stocknewsjournal.com: Today Analysts Focus on Valero Energy Corporation , Amgen Inc.

Amgen Inc Upcoming Events

Upcoming Quarterly ReportApril 27, 2017
Next Earnings ReportJuly 26, 2017

Amgen Inc EPS Estimate

EPSEstimate Date
Quarterly Estimate2.99April 27, 2017

Amgen SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares59 M11 B
Vanguard Group IncCommon Shares52.5 M9.8 B
Capital Research Global InvestorsCommon Shares52.5 M9.8 B
Blackrock IncCommon Shares49.8 M9.3 B
State Street CorpCommon Shares31.9 M6 B
Primecap Management CoCommon Shares22.3 M4.2 B
Northern Trust CorpCommon Shares9.7 M1.8 B

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 122.95 B.

Profitablity

The company has Profit Margin (PM) of 35.46 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 44.49 % which suggests for every 100 dollars of sales it generated a net operating income of 0.44.

Management Efficiency

Amgen Inc has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.

Stock Holders for Amgen

Information
Ratio
Value
At Risk
NASDAQNASDAQ Composite Total Return I 0.0558 (0.57) 
Nasdaq USNasdaq US Shareholder Yield Net(0.0909) (0.7) 
PNC MultiPNC Multi Factor Large Cap Growth A 0.2 (0.64) 
Stlmt IDStlmt ID NASDAQ Biotechnology 0.00  0.00 
XNBINASDAQ Biotechnology Total Retu(0.43) (1.57) 
NASDAQNASDAQ 100 Pre Market Indicator 0.25 (0.65) 
NASDAQNASDAQ 100 After Hours Indicato 0.18 (0.58) 
NASDAQ USNASDAQ US Rising Dividend Achie(0.0469) (0.57) 
NASDAQNASDAQ 100 Equal Weighted 0.0196 (0.55) 
NasdaqNasdaq 0.0882 (0.58) 
SEI LargeSEI Large Cap Value Y(0.13) (0.56) 
RYCFXRydex Biotechnology C(0.33) (1.27) 
NWJCXNationwide Ziegler NYSEArcaTech100 A 0.0441 (0.65) 
JPMorganJPMorgan US Dynamic Plus C(0.0211) (0.64) 
Ivy ValueIvy Value N(0.17) (0.81) 
VYVY Templeton Global Growth S(0.32) (0.54) 
LeggLegg Mason CB US Agrsv Gr A USD G Acc 0.0923 (2.88) 
FC NorthFC North American 3 0.27 (0.86) 
FidelityFidelity Advisor Equity Growth Z 0.0791 (0.45) 
FidelityFidelity Advisor Value Leaders C(0.19) (0.38) 

Technical Drivers

Amgen Inc shows Mean Deviation of 0.6275 and Risk Adjusted Performance of (0.16). Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Amgen Inc which can be compared to its rivals. Please confirm Amgen Inc Treynor Ratio, and the relationship between Standard Deviation and Downside Variance to decide if Amgen Inc is priced correctly providing market reflects its regular price of 169.38 per share. Given that Amgen has Jensen Alpha of (0.33), we suggest you validate Amgen Inc prevailing market performance to make sure the company can sustain itself at future point.

Amgen Inc Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Amgen Inc Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Amgen price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Bonds

Amgen Outstanding Bonds
MaturityCouponRating
031162AA8 8.125%04/01/20978.125
A
031162AV2 5.85%06/01/20175.85
A
031162AW0 6.375%06/01/20376.375
A
031162AX8 6.15%06/01/20186.15
A
031162AY6 6.9%06/01/20386.9
A
031162AZ3 5.7%02/01/20195.7
A
031162BA7 6.4%02/01/20396.4
A
031162BB5 4.5%03/15/20204.5
A
031162BC3 5.75%03/15/20405.75
A
031162BD1 3.45%10/01/20203.45
A
031162BE9 4.95%10/01/20414.95
A
031162BF6 2.3%06/15/20162.3
A
031162BG4 4.1%06/15/20214.1
A
031162BH2 5.65%06/15/20425.65
A
031162BK5 5.15%11/15/20415.15
A
031162BL3 2.5%11/15/20162.5
A
031162BM1 3.875%11/15/20213.875
A
031162BN9 3.625%05/15/20223.625
A
031162BP4 5.375%05/15/20435.375
A
031162BQ2 2.125%05/15/20172.125
A
031162BR0 1.25%05/22/20171.25
A
031162BU3 2.2%05/22/20192.2
A
031162BV1 3.625%05/22/20243.625
A
031162AS9 5.85%06/01/20175.85
A
031162BW9 2.125%05/01/20202.125
NA
031162BX7 2.7%05/01/20222.7
A
031162BY5 3.125%05/01/20253.125
A
031162BZ2 4.4%05/01/20454.4
A

Corporate Filings

Amgen Corporate Reports
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations